Lucentis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
Condition:   Diabetic Macular Edema Interventions:   Drug: intra-vitreal injection of Ranibizumab;   Procedure: anterior chamber paracentesis Sponsor:   Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2023 Category: Research Source Type: clinical trials

Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)
Condition:   Diabetic Macular Edema Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials